KRAS status and epidermal growth factor receptor expression as determinants for anti-EGFR therapies in salivary gland carcinomas
Dahse, Regine, Driemel, Oliver, Schwarz, Stephan, Kromeyer-Hauschild, Katrin, Berndt, Alexander and Kosmehl, Hartwig (2009) KRAS status and epidermal growth factor receptor expression as determinants for anti-EGFR therapies in salivary gland carcinomas. Oral Oncology 45 (9), pp. 826-829.Date of publication of this fulltext: 19 Dec 2024 12:03
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Oral Oncology | ||||
| Publisher: | ELSEVIER SCIENCE BV | ||||
|---|---|---|---|---|---|
| Place of Publication: | AMSTERDAM | ||||
| Volume: | 45 | ||||
| Number of Issue or Book Chapter: | 9 | ||||
| Page Range: | pp. 826-829 | ||||
| Date | 2009 | ||||
| Institutions | Medicine > Lehrstuhl für Mund-, Kiefer- und Gesichtschirurgie | ||||
| Identification Number |
| ||||
| Keywords | CELL LUNG-CANCER; PHASE-II TRIAL; COLORECTAL-CANCER; ONCOLOGY-GROUP; ADVANCED HEAD; MUTATIONS; GEFITINIB; GENE; CHEMOTHERAPY; ERLOTINIB; Epidermal growth factor receptor; KRAS; Mutation screening; Salivary gland carcinomas; EGFR-targeted therapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 66970 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric